AU7311501A - Cosmetic composition and method - Google Patents

Cosmetic composition and method

Info

Publication number
AU7311501A
AU7311501A AU7311501A AU7311501A AU7311501A AU 7311501 A AU7311501 A AU 7311501A AU 7311501 A AU7311501 A AU 7311501A AU 7311501 A AU7311501 A AU 7311501A AU 7311501 A AU7311501 A AU 7311501A
Authority
AU
Australia
Prior art keywords
cosmetic composition
cosmetic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU7311501A
Other languages
English (en)
Inventor
David S Lerner
Gregory Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Quick Med Technologies Inc
University of Florida Research Foundation Inc
Original Assignee
University of Florida
Quick Med Technologies Inc
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, Quick Med Technologies Inc, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of AU7311501A publication Critical patent/AU7311501A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AU7311501A 2000-06-29 2001-06-29 Cosmetic composition and method Pending AU7311501A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21508700P 2000-06-29 2000-06-29
PCT/US2001/020945 WO2002019982A2 (en) 2000-06-29 2001-06-29 Cosmetic composition and method for reducing or preventing wrinkling

Publications (1)

Publication Number Publication Date
AU7311501A true AU7311501A (en) 2002-03-22

Family

ID=22801588

Family Applications (2)

Application Number Title Priority Date Filing Date
AU7311501A Pending AU7311501A (en) 2000-06-29 2001-06-29 Cosmetic composition and method
AU2001273115A Ceased AU2001273115C1 (en) 2000-06-29 2001-06-29 Cosmetic composition and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001273115A Ceased AU2001273115C1 (en) 2000-06-29 2001-06-29 Cosmetic composition and method

Country Status (6)

Country Link
US (1) US6713074B2 (enExample)
EP (1) EP1359897A2 (enExample)
JP (1) JP5106739B2 (enExample)
AU (2) AU7311501A (enExample)
CA (1) CA2414247C (enExample)
WO (1) WO2002019982A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083321A1 (en) * 2001-09-25 2003-05-01 Lerner David S. Composition and method for minimizing or avoiding adverse effects of vesicants
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
CA2526222A1 (en) * 2003-05-16 2004-12-02 Arriva Pharmaceuticals, Inc. Treatment of respiratory disease associated with matrix metalloprotease inhibitors
FR2859908A1 (fr) * 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
JP4803698B2 (ja) * 2004-11-02 2011-10-26 丸善製薬株式会社 抗老化剤、エストロゲン様作用剤、抗男性ホルモン剤、育毛剤、テストステロン５α−レダクターゼ阻害剤、皮膚化粧料及び頭髪化粧料
BRPI0615588A2 (pt) * 2005-08-31 2011-05-24 Serentis Ltd uso de um inibidor de aureolisina para o tratamento de condições inflamatórias da pele caracterizadas por colonização com staphylococcus aureus
US20070142905A1 (en) * 2005-12-16 2007-06-21 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
JP5661994B2 (ja) * 2008-01-04 2015-01-28 クラシエ製薬株式会社 抗ストレス・疲労防止、肌のキメ改善又はシワ改善・防止効果を有する組成物又は内服剤
US20090299466A1 (en) * 2008-06-02 2009-12-03 Medtronic Vascular, Inc. Local Delivery of Matrix Metalloproteinase Inhibitors
US8435541B2 (en) 2010-09-02 2013-05-07 Bath & Body Works Brand Management, Inc. Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
EP3973967A1 (en) 2012-12-21 2022-03-30 Astellas Institute for Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
TWI480057B (zh) * 2013-07-08 2015-04-11 Univ China Medical 咖啡酸醯胺衍生物之應用
US10166412B2 (en) 2014-12-30 2019-01-01 Conopco, Inc. Skin lightening composition comprising 4-hexylresorcinol and ilomastat
CA2971907C (en) * 2014-12-30 2023-08-15 Unilever Plc A skin lightening composition comprising niacinamide and ilomastat
KR102124065B1 (ko) * 2018-08-17 2020-06-17 서울대학교산학협력단 식물 추출물을 함유하는 피부 주름 개선용 조성물
CN114516917B (zh) * 2020-11-20 2022-11-18 广东东阳光药业有限公司 人源化抗TrkA的抗体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892112A (en) 1990-11-21 1999-04-06 Glycomed Incorporated Process for preparing synthetic matrix metalloprotease inhibitors
US5268384A (en) 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
US6338855B1 (en) * 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
TWI234467B (en) 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US5885596A (en) 1997-07-23 1999-03-23 Bristol-Myers Squibb Company Methods and compositions for fine lines and/or wrinkles
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
JP2002533404A (ja) 1998-12-23 2002-10-08 ジー・ディー・サール・アンド・カンパニー 新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
US6139828A (en) 1999-06-02 2000-10-31 Hair Associates, Llc Hair care formulations
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
WO2001043711A1 (en) * 1999-12-14 2001-06-21 Unilever Plc Cosmetic skin conditioning compositions containing red yeast rice extract
US20020010162A1 (en) * 2000-03-02 2002-01-24 Raul Fleischmajer Treatment of psoriasis with matrix metalloproteinase inhibitors

Also Published As

Publication number Publication date
WO2002019982A3 (en) 2003-07-24
JP5106739B2 (ja) 2012-12-26
AU2001273115C1 (en) 2009-03-26
US6713074B2 (en) 2004-03-30
CA2414247A1 (en) 2002-03-14
CA2414247C (en) 2012-11-27
EP1359897A2 (en) 2003-11-12
JP2004508317A (ja) 2004-03-18
AU2001273115B2 (en) 2005-06-16
WO2002019982A2 (en) 2002-03-14
US20020054922A1 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
AU6832101A (en) Composition and method
AU5752601A (en) Splice-region antisense composition and method
AU4163402A (en) Composition and method
GB0008264D0 (en) Novel method and compounds
SG94358A1 (en) Polishing composition and method
AU7311501A (en) Cosmetic composition and method
AU2001286651A1 (en) Microparticle composition and method
GB0020201D0 (en) Cosmetic Composition
HU0104832D0 (en) Cosmetic composition and method
AP2001002305A0 (en) Improved prosthesis and method thereof
AU2002324895A8 (en) Cosmetic kit and method
AU2001233932A1 (en) Method and composition
HUP0303936A3 (en) Novel composition and use
AU2002239775A1 (en) Chemical-library composition and method
GB0028706D0 (en) Cosmetic composition
GB0006867D0 (en) Method and composition for skin lightening
AU7220501A (en) Mortar composition and method
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
AU5104101A (en) Composition and use
GB0107033D0 (en) Method and composition
SG88779A1 (en) Food modification method and composition therefor
GB9929493D0 (en) Composition and method
GB9917409D0 (en) Composition and method
AUPQ723600A0 (en) Composition and method
GB0111734D0 (en) Composition and method